GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003
COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Stage 0 in GOLD does not predict future clinical COPD Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003
Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II Source: Eur Respir J 2005; 26: Suppl. 49, 434s Year: 2005
What is early COPD and why is it important? Source: Eur Respir J, 52 (6) 1801448; 10.1183/13993003.01448-2018 Year: 2018
How to stage airflow limitation (AL) in patients with stable COPD? Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
High prevalence of osteoporosis in COPD patients independent of GOLD stage Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010
Excess lung function decline is associated with GOLD stage 0 Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005
Impact of symptomatology in patients with GOLD stage I COPD Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010
Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
Dynamics of marker of inflammation - sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients. Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021
Total mortality risks in relation to the GOLD stages in a long term follow-up - a special analysis of GOLD stage 0 Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014